AVE avecho biotechnology limited

the positive side if elixia launch ?fails?, page-9

  1. 5,324 Posts.
    And that kind of revenue could easily fund Tpm Oxy & TPM Insulin thru Phase 3 trials Without any placement external funding required . POHs personal care rollout is strategically unique among Biotechs.

    What I would like to know about Cellucreme is whether customers having reduced or removed their cellulite must keep using the product to keep this condition under control? ...... That is do they become customers for life?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $1.335K 381.5K

Buyers (Bids)

No. Vol. Price($)
44 33957138 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8218985 6
View Market Depth
Last trade - 11.13am 07/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.